Peroxisome proliferator-activated receptor gamma (PPARgamma), a fatty acid-activated nuclear receptor, is implicated in adipocyte differentiation and insulin sensitisation. In view of the association of dietary fat intake and bowel disease, the expression of PPARgamma in rodent and human intestine was studied. Expression of PPARgamma mRNA was examined by Northern blot hybridisation, RNase protection, and/or competitive RT-PCR assays, whereas PPARgamma protein levels were evaluated by immunoblotting and immunohistochemistry. PPARgamma mRNA and protein were abundantly expressed in colon relative to the small intestine both in rodents and in man. Interestingly, expression of PPARgamma was primarily localised in the more differentiated epithelial cells in the colon. The level of expression of PPARgamma in colon was similar to the levels seen in adipose tissue. Expression of PPARgamma increased from proximal to distal segments of the colon in man. In Caco-2 and HT-29 human adenocarcinoma cells, PPARgamma expression increased upon differentiation, consistent with PPARgamma being associated with a differentiated epithelial phenotype. High-level expression of PPARgamma was observed in the colon, but not in the small intestine, suggesting a potential role of this nuclear receptor in the colon.

This article has been cited by other articles:

				I. Ikeda, A. Tomimoto, K. Wada, T. Fujisawa, K. Fujita, K. Yonemitsu, Y. Nozaki, H. Endo, H. Takahashi, M. Yoneda, et al. 5-Aminosalicylic Acid Given in the Remission Stage of Colitis Suppresses Colitis-Associated Cancer in a Mouse Colitis Model Clin. Cancer Res., November 1, 2007; 13(21): 6527 - 6531. [Abstract] [Full Text] [PDF]

				W. Su, C. R. Bush, B. M. Necela, S. R. Calcagno, N. R. Murray, A. P. Fields, and E. A. Thompson Differential expression, distribution, and function of PPAR-{gamma} in the proximal and distal colon Physiol Genomics, August 20, 2007; 30(3): 342 - 353. [Abstract] [Full Text] [PDF]

				N. Dali-Youcef, C. Mataki, A. Coste, N. Messaddeq, S. Giroud, S. Blanc, C. Koehl, M.-F. Champy, P. Chambon, L. Fajas, et al. Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure PNAS, June 19, 2007; 104(25): 10703 - 10708. [Abstract] [Full Text] [PDF]

				X. Han, B. Osuntokun, N. Benight, K. Loesch, S. J. Frank, and L. A. Denson Signal Transducer and Activator of Transcription 5b Promotes Mucosal Tolerance in Pediatric Crohn's Disease and Murine Colitis Am. J. Pathol., December 1, 2006; 169(6): 1999 - 2013. [Abstract] [Full Text] [PDF]

				L Dubuquoy, C Rousseaux, X Thuru, L Peyrin-Biroulet, O Romano, P Chavatte, M Chamaillard, and P Desreumaux PPAR{gamma} as a new therapeutic target in inflammatory bowel diseases. Gut, September 1, 2006; 55(9): 1341 - 1349. [Full Text] [PDF]

				D. A. Sarruf, I. Iankova, A. Abella, S. Assou, S. Miard, and L. Fajas Cyclin D3 Promotes Adipogenesis through Activation of Peroxisome Proliferator-Activated Receptor {gamma} Mol. Cell. Biol., November 15, 2005; 25(22): 9985 - 9995. [Abstract] [Full Text] [PDF]

				M. A. Murtaugh, K.-n. Ma, B. J. Caan, C. Sweeney, R. Wolff, W. S. Samowitz, J. D. Potter, and M. L. Slattery Interactions of Peroxisome Proliferator-Activated Receptor {gamma} and Diet in Etiology of Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1224 - 1229. [Abstract] [Full Text] [PDF]

				C. Rousseaux, B. Lefebvre, L. Dubuquoy, P. Lefebvre, O. Romano, J. Auwerx, D. Metzger, W. Wahli, B. Desvergne, G. C. Naccari, et al. Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-{gamma} J. Exp. Med., April 18, 2005; 201(8): 1205 - 1215. [Abstract] [Full Text] [PDF]

				S. Drori, G. D. Girnun, L. Tou, J. D. Szwaya, E. Mueller, X. Kia, R. A. Shivdasani, and B. M. Spiegelman Hic-5 regulates an epithelial program mediated by PPAR{gamma} Genes & Dev., February 1, 2005; 19(3): 362 - 375. [Abstract] [Full Text] [PDF]

				E. A. Jansson, A. Are, G. Greicius, I-C. Kuo, D. Kelly, V. Arulampalam, and S. Pettersson The Wnt/{beta}-catenin signaling pathway targets PPAR{gamma} activity in colon cancer cells PNAS, February 1, 2005; 102(5): 1460 - 1465. [Abstract] [Full Text] [PDF]

				J. Hulit, C. Wang, Z. Li, C. Albanese, M. Rao, D. Di Vizio, S. Shah, S. W. Byers, R. Mahmood, L. H. Augenlicht, et al. Cyclin D1 Genetic Heterozygosity Regulates Colonic Epithelial Cell Differentiation and Tumor Number in ApcMin Mice Mol. Cell. Biol., September 1, 2004; 24(17): 7598 - 7611. [Abstract] [Full Text] [PDF]

				C. L. Varley, J. Stahlschmidt, W.-C. Lee, J. Holder, C. Diggle, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate Role of PPAR {gamma} and EGFR signalling in the urothelial terminal differentiation programme J. Cell Sci., April 15, 2004; 117(10): 2029 - 2036. [Abstract] [Full Text] [PDF]

				A. W. Bull, K. R. Steffensen, J. Leers, and J. J. Rafter Activation of PPAR {gamma} in colon tumor cell lines by oxidized metabolites of linoleic acid, endogenous ligands for PPAR {gamma} Carcinogenesis, November 1, 2003; 24(11): 1717 - 1722. [Abstract] [Full Text] [PDF]

				R. A. Gupta, P. Sarraf, E. Mueller, J. A. Brockman, J. J. Prusakiewicz, C. Eng, T. M. Willson, and R. N. DuBois Peroxisome Proliferator-activated Receptor {gamma}-mediated Differentiation: A MUTATION IN COLON CANCER CELLS REVEALS DIVERGENT AND CELL TYPE-SPECIFIC MECHANISMS J. Biol. Chem., June 13, 2003; 278(25): 22669 - 22677. [Abstract] [Full Text] [PDF]

				M. Wick, G. Hurteau, C. Dessev, D. Chan, M. W. Geraci, R. A. Winn, L. E. Heasley, and R. A. Nemenoff Peroxisome Proliferator-Activated Receptor-gamma Is a Target of Nonsteroidal Anti-Inflammatory Drugs Mediating Cyclooxygenase-Independent Inhibition of Lung Cancer Cell Growth Mol. Pharmacol., November 1, 2002; 62(5): 1207 - 1214. [Abstract] [Full Text] [PDF]

				C. Brendel, K. Schoonjans, O. A. Botrugno, E. Treuter, and J. Auwerx The Small Heterodimer Partner Interacts with the Liver X Receptor {alpha} and Represses Its Transcriptional Activity Mol. Endocrinol., September 1, 2002; 16(9): 2065 - 2076. [Abstract] [Full Text] [PDF]

				J. M. Mariadason, D. Arango, G. A. Corner, M. J. Aranes, K. A. Hotchkiss, W. Yang, and L. H. Augenlicht A Gene Expression Profile That Defines Colon Cell Maturation in Vitro Cancer Res., August 15, 2002; 62(16): 4791 - 4804. [Abstract] [Full Text] [PDF]

				R. A. Gupta and R. N. Dubois Controversy: PPARgamma as a target for treatment of colorectal cancer Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G266 - G269. [Abstract] [Full Text] [PDF]

				L. Capparuccia, D. Marzioni, A. Giordano, F. Fazioli, M. De Nictolis, N. Busso, T. Todros, and M. Castellucci PPAR{gamma} expression in normal human placenta, hydatidiform mole and choriocarcinoma Mol. Hum. Reprod., June 1, 2002; 8(6): 574 - 579. [Abstract] [Full Text] [PDF]

				A. Tarrade, K. Schoonjans, J. Guibourdenche, J. M. Bidart, M. Vidaud, J. Auwerx, C. Rochette-Egly, and D. Evain-Brion PPAR{gamma}/RXR{alpha} Heterodimers Are Involved in Human CG{beta} Synthesis and Human Trophoblast Differentiation Endocrinology, October 1, 2001; 142(10): 4504 - 4514. [Abstract] [Full Text] [PDF]

				P. Desreumaux, L. Dubuquoy, S. Nutten, M. Peuchmaur, W. Englaro, K. Schoonjans, B. Derijard, B. Desvergne, W. Wahli, P. Chambon, et al. Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (RXR)/Peroxisome Proliferator-activated Receptor {{gamma}} (PPAR{{gamma}}) Heterodimer: A Basis for New Therapeutic Strategies J. Exp. Med., April 2, 2001; 193(7): 827 - 838. [Abstract] [Full Text] [PDF]

				R. F. Morrison and S. R. Farmer Hormonal Signaling and Transcriptional Control of Adipocyte Differentiation J. Nutr., December 1, 2000; 130 (12): 3116S - 3121S. [Abstract] [Full Text] [PDF]

				R. A. Gupta, J. A. Brockman, P. Sarraf, T. M. Willson, and R. N. DuBois Target Genes of Peroxisome Proliferator-activated Receptor gamma in Colorectal Cancer Cells J. Biol. Chem., August 3, 2001; 276(32): 29681 - 29687. [Abstract] [Full Text] [PDF]